Loading organizations...
Key people at LifeLink.
LifeLink was founded in 2020 by Francisca Peixoto (Founder & Investment Manager).
Lifelink Systems delivers a conversational AI platform to optimize patient engagement for healthcare organizations. Its technology automates complex patient workflows through intuitive digital conversations, effectively turning smartphones into virtual assistants. This approach provides personalized interactions, significantly improving the patient experience for hospitals and life sciences companies.
Co-founded in 2015 by Justin Mardjuki, Jacob Heitler, Greg Johnsen, and Ori Sasson, Lifelink Systems recognized the limitations of complex digital tools in healthcare. Their insight centered on conversation as the most natural human interface, allowing patients to effortlessly interact with sophisticated IT systems without specialized training.
The platform serves healthcare providers seeking streamlined patient interactions. Lifelink Systems aims for conversational AI to augment care teams, automating routine, high-volume tasks. This frees human resources and elevates service quality. The company’s vision is to simplify complex healthcare processes through intelligent digital assistants.
LifeLink was founded in 2020 by Francisca Peixoto (Founder & Investment Manager).
Key people at LifeLink.
LifeLink has 3 tracked investments across 3 companies. The latest tracked deal is $77.0M Series B in Crossbow Therapeutics in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 18, 2026 | Crossbow Therapeutics | $77.0M Series B | Arkin BIO Ventures, Taiho Ventures | BVF Partners, ELI Lilly And Company, Hamilton Square Partners Management, Libbs Ventures, Mirae Asset Venture Investment, MPM Capital, Pfizer Ventures, Polaris Partners, Sixty Degree Capital, The Leukemia & Lymphoma Society |
| May 1, 2025 | HAYA Therapeutics SA | $65.0M Series A | Soffinova Partners, Earlybird Venture Capital | AbbVie Ventures, Apollo Health Ventures, Broadview Ventures, Humboldt Fund, 4See Ventures, Alexandria Venture Investments, Athos, BERNINA BioInvest, Benjamin Kreitman, ELI Lilly And Company, NanoDimension, Schroders Capital |
| Oct 1, 2022 | Ochre Bio | $30.0M Series A | — | Apollo Health Ventures, BoxOne Ventures, Aniq Kassam, Hoxton Ventures, Khosla Ventures, Alice Zhang, Kristen Fortney, Martin Chavez, Aixthera, Backed, Hermes Epitek, LifeForce Capital, Selvedge |
